Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
WHAT IT'S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic monitoring technology.
Established in 2017, Nutromics has been developing a "lab-in-a-patch," which uses DNA sensor technology to track multiple targets, such as...
Morgan Health, JPMorgan Chase's healthcare business unit, announced a $20 million strategic investment in home diagnostics startup LetsGetChecked.
The investment was made as part of a Series D-2 round led by Casdin Capital and Transformation Capital. LetsGetChecked closed a $150 million Series D round last year, building on raises in 2018, 2019 and 2020.
WHAT THEY DO
LetsGetChecked offers at-...
Medtech startup Nutromics has received a $14 million investment from strategic investors, including Dexcom Ventures, VU Venture Partners, and Artesian Investments.
Founded in 2017, the company is developing a continuous diagnostic monitoring platform called lab-in-a-patch that uses DNA sensor technology to track multiple targets in the human body, including disease biomarkers and hard-to-dose...
Less than a year after it went public, diagnostics company Cue Health has laid off 170 manufacturing workers.
First reported by STAT, Cue said the layoffs reflected larger economic conditions, as well as the federal government's recent move to divert funding from COVID-19 testing to secure vaccines and treatments.
The diagnostics company is best known for its at-home molecular COVID-19 test,...
At-home diagnostics company LetsGetChecked announced Tuesday it has completed the acquisition of BioIQ, a company that works with employers and health plans to offer lab testing, health screening and vaccination services.
As part of the deal, which was first announced in November last year, BioIQ will operate as a subsidiary of LetsGetChecked. The closing comes weeks after the company revealed...
Indian digital health startup MFine has launched a cancer screening feature on its app in partnership with oncology research and solutions provider Datar Cancer Genetics.
MFine users can now book a range of cancer diagnostic tests from Datar's EasyCheck.
EasyCheck is a non-invasive, radiation-free test for early cancer detection. It has three types of test: EasyCheck360 detects cancer from...
Diagnostics giant Labcorp is stepping deeper into the digital health space with the launch of Labcorp OnDemand, an online platform where users can order tests and possibly collect samples at home.
Patients choose tests through the platform and a physician can approve and review requests without a required doctor's visit. Some tests allow patients to collect samples in their homes, while others...
An NHS initiative to accelerate the uptake of innovative medical devices, diagnostics and digital products is due to launch in April.
A consultation into the MedTech Funding Mandate took place in December 2019, but the launch was delayed due to COVID-19.
Under the policy, NHS England and NHS Improvement will identify medical technologies which have been assessed and recommended by NICE as being...
Cue Health, a rapid diagnostics startup with a connected testing device platform, has been awarded $481 million from HHS and the Department of Defense (DoD) to expand production of a COVID-19 molecular test that received an Emergency Use Authorization back in June.
According to announcements from the government and the startup, the money will be used to deliver six million COVID-19 molecular...
Nurx, a startup known for online purchase and delivery of home health tests, birth control and other sensitive treatments for women, has tacked on another $22.5 million in Series C funding.
Closed in May, the raise included new backers Trustbridge, Comcast Ventures and Wittington Ventures, as well as prior backers Union Square Ventures and Kleiner Perkins Digital Growth Fund. This brings the...
